|
|
||||||||
Eur J Cardiothorac Surg 1999;16:S69-S72
© 1999 Elsevier Science NL
Department of Cardiac Surgery, University G. D'Annunzio', c/o Ospedale San Camillo De Lellis, Via C. Forlanini, 50, 66100 Chieti, Italy
* Corresponding author. Tel.: +39-871-358653; fax: +39-871-402239 (Email: calafiore{at}unich.it).
| Abstract |
|---|
|
|
|---|
Key Words: Coronary revascularization Beating heart surgery
| 1. Introduction |
|---|
|
|
|---|
We herein report our experience in myocardial revascularization without CPB via median sternotomy to analyze the early- and mid-term results compared with patients who had myocardial revascularization with CPB.
| 2. Materials and methods |
|---|
|
|
|---|
|
2.2 Surgical technique
Anesthesia was induced and maintained as previously described [3]. The mammary arteries were harvested and skeletonized [5]; the remaining conduits were harvested and prepared as previously described [6,7]. A total of 2 mg/kg of heparin was administered. The target coronary vessels were explored and the surgical strategy confirmed. Four slings (length 50 cm, width 3 cm) were enrolled and passed, two through the transverse sinus (TS) and two behind the inferior vena cava (IVC) [3]. Four deep pericardial sutures were passed in the mobile posterior pericardium, at the level of the left superior and inferior pulmonary veins and between the latter one and the inferior vena cava (Ricardo Lima, personal communication). The maneuvers that allowed exposure of all the coronary vessels were previously reported [3]. The traction on the pericardial sutures allowed to reach a more vertical position of the heart and an easier access to the proximal portion of the coronary vessels in the lateral and inferoposterior walls.
The coronary arteries were occluded before the anastomoses [3]. The left anterior descending (LAD) and the main right coronary artery (RCA) were occluded proximally and distally the anastomotic site, whereas the other branches only proximally. An O2 blower made the operative field dry at the moment of the anastomosis.
The coronary vessels were stabilized using the MV system (CardioThoracic System, Cuppertino, CA, USA).
Once exposure and stabilization were obtained, the target coronary vessel was incised and the anastomosis was performed as previously described [3]. Blood loss during the procedure was reinfused, when necessary, using a cell saver (DIDECO, Mirandola, Modena, Italy). Protamine was reversed 0.5:1 and the wound closed in the usual fashion.
2.3 Postoperative course
The patients were admitted in the ICU, where they remained until extubation and clinical stabilization; intravenous diltiazem was infused. The patients were transferred to the ward generally on the same day of the operation or in the first postoperative day; diltiazem (60 mg three times a day) was given orally and continued for 4 weeks. In the morning of the first postoperative day all the infusion lines were removed, as well as the drainage tubes and the patients were mobilized. If the patient agreed, control angiography was performed before discharging or a few days or a few weeks later. One month postoperatively all the patients were seen in the outpatient clinic, with the result of a stress test performed without medical treatment.
In order to stratify properly the risk factors for each group with regard to early mortality and prediction of cerebrovascular accidents (CVAs), the risk factors for early death derived by the New York State data base for 1995 was used (Table 2 ) as well as the nomogram proposed by Newman et al. [8]
|
2 test for categorical variables. Survival and event free survival curves were obtained with the KaplanMeier method (BMDP 1L software). The statistical significance was calculated with the MantelCox test and z-test. Values of P<0.05 were considered significant. | 3. Results |
|---|
|
|
|---|
|
|
|
|
|
| 4. Discussion |
|---|
|
|
|---|
However, in our hands a significant number of patients could not be revascularized without CPB because of technical or hemodynamic factors. Moreover, the real benefit for the patients has still to be clearly demonstrated. In our experience the primary end points (death, incidence of myocardial infarction) are similar in both groups. Even if there is evidence that some factors related to a better cardiac outcome (lower incidence of inotropes and lower CKMB peaks) are prevalent in Group A, their importance is questionable in the long-term outcome.
Some of the secondary end points (awaking time, bleeding, transfused patients, ICU stay, postoperative in hospital stay) are undoubtedly favorable for the patients operated on without CPB; however, their importance for early outcome is minor. In fact, many of the techniques developed for surgery without CPB (different anesthesiological protocols, ICU discharge in the same day, reduced postoperative in hospital stay) are now applied also to the patients operated on with CPB, with excellent results. The difference between groups, even if statistically significant, is 0.7 h for awaking time, 6.8 h for ICU stay and 1 day for postoperative in hospital stay. It is likely that in the near future these figures will have a tendency to equalization. Bleeding is significantly less in Group A, as well as the incidence of transfused patients; this aspect will likely remain similar, as in the patients operated on without CPB coagulation disorders will be always lacking.
Crude mortality was not different and the risk adjusted mortality was similar. The CVA incidence was also similar, even if a statistically significant reduction in comparison with the expected incidence was shown by our data.
The great benefit from myocardial revascularization without CPB could be in the subgroup of high risk patients for the presence of severe comorbidities. This is our feeling, however this aspect is very difficult to demonstrate scientifically.
In conclusion, we think that myocardial revascularization without CPB is a safe technique that can give good results in the mid-term, provided a good anastomosis could be done. This strategy is not clearly superior to conventional techniques, even if our data allows us suppose that the incidence of CVA could be reduced in patients operated on without CPB. Moreover it is likely that selected subgroups of patients with high risk factors can benefit from it. A longer follow-up is necessary to demonstrate its validity in the long-term using the current techniques.
| Footnotes |
|---|
Presented at the 2nd MITSIG International Symposium: Controversies in Cardiothoracic Surgery, Hong Kong, November 2021, 1998. | References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. C. Guida Anterolateral thoracotomy for myocardial revascularization MMCTS, May 12, 2006; 2006(0512): 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Calafiore, G. Di Giammarco, G. Teodori, A. L. Iaco, M. Pano, M. Contini, G. Vitolla, and M. Di Mauro Bilateral internal thoracic artery grafting with and without cardiopulmonary bypass: Six-year clinical outcome J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 340 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Reston, S. J. Tregear, and C. M. Turkelson Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting Ann. Thorac. Surg., November 1, 2003; 76(5): 1510 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Srivastava, K. N. Patel, R. Skantharaja, R. Barrera, D. Nanayakkara, and V. Srivastava Off-pump complete revascularization through a left lateral thoracotomy (ThoraCAB): the first 200 cases Ann. Thorac. Surg., July 1, 2003; 76(1): 46 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Sabik Does Off-Pump Coronary Surgery Reduce Morbidity and Mortality? A Review of the Recent Literature Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2002; 6(4): 313 - 317. [Abstract] [PDF] |
||||
![]() |
R. Cartier, M. Leacche, and P. Couture Changing pattern in beating heart operations: use of skeletonized internal thoracic artery Ann. Thorac. Surg., November 1, 2002; 74(5): 1548 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Sabik, A. M. Gillinov, E. H. Blackstone, C. Vacha, P. L. Houghtaling, J. Navia, N. G. Smedira, P. M. McCarthy, D. M. Cosgrove, and B. W. Lytle Does off-pump coronary surgery reduce morbidity and mortality? J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Vassiliades Jr, J. L. Nielsen, and J. L. Lonquist Hemodynamic collapse during off-pump coronary artery bypass grafting Ann. Thorac. Surg., June 1, 2002; 73(6): 1874 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Anyanwu, S. Al-Ruzzeh, S. J. George, R. Patel, M. H. Yacoub, and M. Amrani Conversion to off-pump coronary bypass without increased morbidity or change in practice Ann. Thorac. Surg., March 1, 2002; 73(3): 798 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riha, M. Danzmayr, G. Nagele, L. Mueller, D. Hoefer, H. Ott, G. Laufer, and J. Bonatti Off pump coronary artery bypass grafting in EuroSCORE high and low risk patients Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 193 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Calafiore, M. Di Mauro, M. Contini, G. Di Giammarco, M. Pano, G. Vitolla, A. Bivona, R. Carella, and S. D'Alessandro Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome Ann. Thorac. Surg., August 1, 2001; 72(2): 456 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Paulis, L. Colagrande, M. De Cotiis, and L. Chiariello Heart positioner: a device to easily expose all coronary arteries during beating heart operations Ann. Thorac. Surg., December 1, 2000; 70(6): 2169 - 2170. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |